FdaApplication
NDA 220626
Identifiers
- fda_app_no: NDA220626
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | NDA |
| approval_date | 2026-03-30 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EPINEPHRINE | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
| EPINEPHRINE | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
2 products